Hudson Bay Capital Management
FBIO icon

Hudson Bay Capital Management’s Fortress Biotech FBIO Stock Holding History

Hudson Bay Capital Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-327,235
Closed -$985K – 780
2023
Q4 		$985K Buy
+327,235
New +$865K 0.01% 523
2015
Q1 		– Sell
-11,556
Closed -$423K – 185
2014
Q4 		$423K Sell
11,556
-3,000
-21% -$88.4K 0.01% 160
2014
Q3 		$459K Buy
+14,556
New +$387K 0.01% 186

Other funds holding FBIO

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudson Bay Capital Management's FBIO Position: Q1 2024 in Review

Hudson Bay Capital Management sold out of Fortress Biotech (FBIO) in Q1 2024, closing a stake of 327,235 shares — an estimated $985K sold.

Hudson Bay Capital Management first reported a position in FBIO in Q3 2014 and held it in 3 quarters. The position peaked at $985K in Q4 2023. 40 funds tracked by Wall St. Rank hold FBIO as of Q1 2024.

  • Hudson Bay Capital Management reported no remaining Fortress Biotech position as of Q1 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 327,235 Fortress Biotech shares in Q1 2024, an estimated $985K.
  • Hudson Bay Capital Management first reported a position in Fortress Biotech in Q3 2014 and held it in 3 quarters.
  • Hudson Bay Capital Management's Fortress Biotech position peaked at $985K in Q4 2023.
  • 40 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2024.

Based on Hudson Bay Capital Management's 13F filing for Q1 2024, filed 15 May 2024.